Journal of Diabetes and Its Complications
Volume 24, Issue 2 , Pages 129-141, March 2010

The value of self-monitoring of blood glucose: a review of recent evidence

  • Andrew St John

      Affiliations

    • ARC Consulting, Perth, W Australia 6050, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 8 9272 4899; fax: +61 8 9272 4899.
  • ,
  • Wendy A. Davis

      Affiliations

    • School of Medicine and Pharmacology, University of Western Australia, Fremantle, W Australia 6160, Australia
  • ,
  • Christopher P. Price

      Affiliations

    • Department of Clinical Biochemistry, University of Oxford, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK
  • ,
  • Tim M.E. Davis

      Affiliations

    • School of Medicine and Pharmacology, University of Western Australia, Fremantle, W Australia 6160, Australia

Received 8 May 2008; received in revised form 5 August 2008; accepted 6 January 2009. published online 23 February 2009.

Abstract 

Aims

To review the recent literature relating to the role of self-monitoring of blood glucose (SMBG) and glycemic control.

Methods

Medline and EMBASE databases were searched between 1996 and June 2008 using terms that included diabetes mellitus, self-care, and blood glucose self monitoring. Both experimental and nonexperimental studies with HbA1c as an outcome measure were included. A meta-analysis was performed on randomized controlled trials (RCTs) in type 2 diabetes which met the inclusion criteria.

Results

From 1102 relevant papers, 34 original containing 38 separate studies were identified as being published between 2000 and June 2008. There were 23 studies of type 2 diabetes and, of these, 13 were nonexperimental and 10 experimental, including six RCTs. The results of five of these RCTs in non–insulin-treated type 2 diabetic patients were combined in a meta-analysis with two earlier RCTs which yielded a significant pooled SMBG-related decrease in HbA1c of −0.22 (95% CI −0.34% to −0.11%).

Conclusions

The present meta-analysis showed an SMBG-related HbA1c reduction in non–insulin-treated type 2 diabetes patients that was similar to that in previous systematic reviews but in a substantially larger patient sample. This finding is consistent with most observational studies of similarly treated patients.

Keywords: Self-monitoring of blood glucose, Diabetes, Glycemic control, Evidence-based medicine, Meta-analysis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1056-8727(09)00004-X

doi:10.1016/j.jdiacomp.2009.01.002

Journal of Diabetes and Its Complications
Volume 24, Issue 2 , Pages 129-141, March 2010